Similarly, hepatocellular carcinoma cell-derived exosomes deliver miR-210 as a signalling molecule to endothelial cells, and miR-210 promotes tumour angiogenesis through two targets, SMAD4 and STAT6 (27). This evidence concerns the gene STAT6 and hepatocellular carcinoma.